E/E' ratio is more sensitive than E/A ratio for detection of left ventricular diastolic dysfunction in patients with systemic sclerosis

Clinical and Experimental Rheumatology

Volumn 28, Issue 2 SUPPL. 58, 2010, Pages

  Lee, Sang Won ^a   Choi, Eui Young ^a   Jung, Sang Youn ^a   Choi, Sang Tae ^a   Lee, Soo Kon ^a   Park, Yong Beom ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Diastolic function; Left ventricle; Systemic sclerosis; Tissue doppler imaging

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CARBON MONOXIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DIAGNOSTIC AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; EARLY FILLING AND EARLY DIASTOLIC MITRAL ANNULAR VELOCITY RATIO; EARLY FILLING AND LATE FILLING RATIO; FEMALE; HEART LEFT VENTRICLE FILLING; HUMAN; HYPERTENSION; KOREA; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; TWO DIMENSIONAL ECHOCARDIOGRAPHY; DIASTOLE; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; KOREAN (PEOPLE); LUNG DIFFUSION CAPACITY; M MODE ECHOCARDIOGRAPHY; TISSUE DOPPLER IMAGING;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARBON MONOXIDE; CARDIAC OUTPUT; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; SCLERODERMA, SYSTEMIC; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77956624207     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. HARRIS ED JR, BUDD RC, GENOVESE MC, FIRESTEIN GS, SARGENT JS, SLEDGE CB: Kelley's Textbook of Rheumatology. 7th ed. p. 1279, USA, Elsevier Saunders, 2005.
2. KARASSA FB, IOANNIDIS JP: Mortality in systemic sclerosis. Clin Exp Rheumatol 2008; 26(Suppl. 51): S85-93.
3. ALLANORE Y, AVOUAC J, KAHANA: Systemic sclerosis: an update in 2008. Joint Bone Spine 2008; 75: 650-5.
4. VALENTINI G, VITALE DF, GIUNTA A et al.: Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve. Ann Rheum Dis 1996; 55: 455-60.
5. AGUGLIA G, SGRECCIA A, BERNARDO ML et al.: Left ventricular diastolic function in systemic sclerosis. J Rheumatol 2001; 28: 1563-7.
6. AGUGLIA G, SGRECCIA A, BERNARDO ML et al.: Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis. J Rheumatol 2005; 32: 1273-8.
7. LINDQVIST P, CAIDAHL K, NEUMAN-ANDERSEN G et al.: Disturbed right ventricular diastolic function in patients with systemic sclerosis: a Doppler tissue imaging study. Chest 2005; 128: 755-63.
8. GIUNTA A, TIRRI E, MAIONE S et al.: Right ventricular diastolic abnormalities in systemic sclerosis. Relation to left ventricular involvement and pulmonary hypertension. Ann Rheum Dis 2000; 59: 94-8.
9. VALENTINI G, MATUCCI-CERINIC M: Disease-specific quality indicators, guidelines and outcome measures in scieroderma. Clin Exp Rheumatol 2007; 25 (Suppl. 47): 159-62.
10. STODDARD MF, PEARSON AC, KERN MJ, RATCLIFF J, MROSEK DG, LABOVITZ AJ: Influence of alteration in preload on the pattern of left ventricular diastolic filling as assessed by Doppler echocardiography in humans. Circulation 1989; 79: 1226-36.
11. OMMEN SR, NISHIMURA RA, APPLETON CP et al.: Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler- catheterization study. Circulation 2000; 102: 1788-94.
12. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581-90.
13. HACHULLA E, GRESSIN V, GUILLEVIN L et al.: Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005; 52: 3792-800.
14. MEDSGER TA JR, SILMAN AJ, STEEN VD et al.: A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999; 26: 2159-67.
15. QUINONES MA, WAGGONER AD, REDUTO LA et al.: A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation 1981; 64: 744-53.
16. YOCK PG, POPP RL: Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984; 70: 657-62.
17. IOANNIDIS JP, VLACHOYIANNOPOULOS PG, HAIDICH AB et al.: Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005; 118: 2-10.
18. GOLDMAN AP, KOTLER MN: Heart disease in scleroderma. Am Heart J 1985; 110: 1043-6.
19. SACKNER MA, HEINZ ER, STEINBERG AJ: The heart in scleroderma. Am J Cardiol 1966; 17: 542-59.
20. BULKLEY BH, RIDOLFI RL, SALYER WR, HUTCHINS GM: Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation 1976; 53: 483-90.
21. DESWAL A, FOLLANSBEE WP: Cardiac involvement in scleroderma. Rheum Dis Clin North Am 1996; 22: 841-60.
22. JANOSIK DL, OSBORN TG, MOORE TL, SHAH DG, KENNEY RG, ZUCKNER J: Heart disease in systemic sclerosis. Semin Arthritis Rheum 1989; 19: 191-200.
23. O'CONNOR CM, GATTIS WA, SHAW L, CUFFE MS, CALIFF RM: Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function. Am J Cardiol 2000; 86: 863-7.
24. BROGAN WC 3RD, HILLIS LD, FLORES ED, LANGE RA: The natural history of isolated left ventricular diastolic dysfunction. Am J Med 1992; 92: 627-30.
25. RAKOWSKI H, APPLETON C, CHAN KL et al.: Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr 1996; 9: 736-60.
26. APPLETON CP, FIRSTENBERG MS, GARCIA MJ, THOMAS JD: The echo-Doppler evaluation of left ventricular diastolic function. A current perspective. Cardiol Clin 2000; 18: 513-46.
27. LITTLE WC, DOWNES TR: Clinical evaluation of left ventricular diastolic performance. Prog Cardiovasc Dis 1990; 32: 273-90.
28. SOHN DW, CHAI IH, LEE DJ et al.: Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997; 30: 474-80.
29. LEE SW, PARK MC, PARK YB, LEE SK: E/E' ratio is more sensitive than E/A ratio for detection of left ventricular diastolic dysfunction in systemic lupus erythematosus. Lupus 2008; 17: 195-201.
30. HA JW, CHO JR, KIM JM et al.: Tissue Doppler-derived indices predict exercise capacity in patients with apical hypertrophic cardiomyopathy. Chest 2005; 128: 3428-33.
31. KAHAN A, ALLANORE Y: Primary myocardial involvement in systemic sclerosis. Rheumatology (Oxford) 2006; 45 (Suppl. 4): iv14-7.
32. YAMAMOTO K, MANO T, YOSHIDA J et al.: ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure. J Hypertens 2005; 23: 393-400.
33. ALLANORE Y, MEUNE C, VONK MC et al.: Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUS-TAR) database of systemic sclerosis patients. Ann Rheum Dis 2010; 69: 218-21.